Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A PLOTKIN

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Vaccine|March 1, 1986
Response of adult human volunteers to oral administration of bovine and bovine/human reassortant rotavirusesH F Clark, P A Offit, K T Dolan, et al.
Lancet (London, England)|June 7, 1997
Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infantsJ Lang, G H Duong, V G Nguyen, et al.
The Journal of Infectious Diseases|August 1, 1996
Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccinesJ B Wang, S P Adler, S Hempfling, et al.
The Journal of Infectious Diseases|January 1, 1995
Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing ageS P Adler, S E Starr, S A Plotkin, et al.
Pediatrics|February 1, 1986
Outbreak of cryptosporidiosis in a day-care centerG Alpert, L M Bell, C E Kirkpatrick, et al.
Journal of Clinical Microbiology|May 1, 1985
Epidemiology of rotavirus electropherotypes determined by a simplified diagnostic technique with RNA analysisK T Dolan, E M Twist, P Horton-Slight, et al.
Pediatric Infectious Disease|May 1, 1986
Vancomycin pharmacokinetics in infants: relationships to indices of maturationD H Schaible, M L Rocci, G A Alpert, et al.
Vaccine|June 28, 2001
Optimization of DNA immunization against human cytomegalovirusV Endrész, K Burián, K Berencsi, et al.
Developments in Biological Standardization|January 1, 1995
The safety and use of canarypox vectored vaccinesS A Plotkin, M Cadoz, B Meignier, et al.
Vaccine|March 17, 1999
Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunizationV Endresz, L Kari, K Berencsi, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Vaccine|March 1, 1986
Response of adult human volunteers to oral administration of bovine and bovine/human reassortant rotavirusesH F Clark, P A Offit, K T Dolan, et al.
Lancet (London, England)|June 7, 1997
Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infantsJ Lang, G H Duong, V G Nguyen, et al.
The Journal of Infectious Diseases|August 1, 1996
Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccinesJ B Wang, S P Adler, S Hempfling, et al.
The Journal of Infectious Diseases|January 1, 1995
Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing ageS P Adler, S E Starr, S A Plotkin, et al.
Pediatrics|February 1, 1986
Outbreak of cryptosporidiosis in a day-care centerG Alpert, L M Bell, C E Kirkpatrick, et al.
Journal of Clinical Microbiology|May 1, 1985
Epidemiology of rotavirus electropherotypes determined by a simplified diagnostic technique with RNA analysisK T Dolan, E M Twist, P Horton-Slight, et al.
Pediatric Infectious Disease|May 1, 1986
Vancomycin pharmacokinetics in infants: relationships to indices of maturationD H Schaible, M L Rocci, G A Alpert, et al.
Vaccine|June 28, 2001
Optimization of DNA immunization against human cytomegalovirusV Endrész, K Burián, K Berencsi, et al.
Developments in Biological Standardization|January 1, 1995
The safety and use of canarypox vectored vaccinesS A Plotkin, M Cadoz, B Meignier, et al.
Vaccine|March 17, 1999
Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunizationV Endresz, L Kari, K Berencsi, et al.
Pageof 16